Legence Corp. dropped 9.1% on Tuesday to $63.66, extending a post-earnings slide that has now erased the call-heavy optimism that defined positioning heading into the August 13 print.
The earnings reaction delivered exactly the kind of downside the stock's history had flagged as a risk. The one-day move after the August 13 release came in at -3.4%, a relatively contained initial dip — but the selling has continued, and the stock is now down nearly 7% over the past month from pre-earnings levels. Tuesday's 9% session was the sharpest single-day decline since the pre-earnings note warned that history of sharp post-print drops meant the setup was "anything but routine." What changed is the magnitude of the follow-through, not the direction. The next earnings event is pencilled in for November 13, leaving three months for the market to reassess.
Positioning has barely flinched in response. Short interest, which had been unwinding steadily through July, ticked up 1.7% on Tuesday to 7.2% of the free float — but remains down 13% on the week and nearly 29% over the past month. The covering trend that began in earnest around July 23-24 is still the dominant story: shorts have gone from roughly 6.2 million shares to just over 4.2 million. The borrow market confirms there is no squeeze dynamic at play. Availability is running at 1,342% of current short interest — enormously loose — and cost to borrow is just 0.48%, barely changed from the 0.50% level flagged before earnings. The short score has ticked down to 44.5 from a recent high of 47.4 on August 10, drifting lower even as the stock sold off, which says the lending market sees no incremental urgency from bears. Options remain call-skewed: the put/call ratio is 0.25, still near its lowest level of the past year and well below the 20-day average of 0.56. The collapse in the PCR from 1.24 in late July has not reversed despite Tuesday's drop — call demand is holding.
The Street has responded to the print with a flurry of target adjustments, and the tone is notably mixed. B of A Securities raised its target from $105 to $116 while keeping a Buy. Tigress Financial lifted its target to $130. Guggenheim reiterated Buy at $115. BMO Capital edged its target to $105 from $100 and held Outperform. The outlier is BTIG, which cut its target sharply from $120 to $100 while keeping its Buy rating — the most direct acknowledgment that the print disappointed on some dimension. The mean price target across the coverage sits near $102, implying more than 60% upside from the current $63.66 close, though that gap partly reflects the distance the stock has fallen since many targets were set. Barclays holds an Equal-Weight at $80 — the lone outright cautious voice. The bull case rests on record Q4 revenues of $737.6 million, a $1.5 billion backlog, and exposure to data-center and healthcare construction. The bear case centres on organic growth slowing below expectations and margin pressure from fixed-fee contracts and labour costs. Factor scores add nuance: EPS momentum ranks in the 92nd–96th percentile over both 30 and 90 days, which supports the bull camp's growth narrative. EPS surprise, however, ranks in just the 4th percentile — the lowest possible reading — suggesting the print itself fell short of what analysts had modelled.
The institutional picture shows Blackstone still the dominant holder at 25.3% of shares, though the firm trimmed 5.9 million shares as of June 30. BlackRock added 1.9 million shares in the same period. First Trust built a new position of over 3 million shares as recently as July 31. The insider data is stale — the most recent disclosed trades were Blackstone-entity sells in April at $54 — so the register tells a story of a sponsor gradually distributing, not of management conviction buying at current levels.
What to watch is whether the call-skewed options market reprices in response to the post-earnings drift, and whether BTIG's target cut — the sharpest downward revision in the recent batch — draws other analysts to revisit assumptions on organic growth and margin trajectory before the November 13 print.
See the live data behind this article on ORTEX.
Open LGN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
